Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina

• US 4,160,452 A
• Filed: 04/07/1977
• Issued: 07/10/1979
• Est. Priority Date: 04/07/1977
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Theeuwes, Felix
• Primary Examiner(s): Padgett, Benjamin R.
• Assistant Examiner(s): Gron, T. S.
• Application Number:
  US05/785,582
• Time in Patent Office: 824 Days
• Field of Search: 128/260, 128/272, 128/130, 128/127, 128/213, 424/19-22
• US Class Current: 424/427
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
• CPC Class Codes: B32B 2250/02 2 layers
• CPC Class Codes: B32B 2270/00 Resin or rubber layer containing a blend of at least two different polymers
• CPC Class Codes: B32B 23/08 of synthetic resin
• CPC Class Codes: B32B 2305/026 Porous
• CPC Class Codes: B32B 2307/7265 Non-permeable
• CPC Class Codes: B32B 2317/18 Cellulose, modified cellulose or cellulose derivatives, e.g. viscose B32B2317/10, B32B2317/12, B32B2317/16 take precedence

Abstract

An osmotic therapeutic system for delivering a beneficial drug is disclosed. The system comprises a drug delivery module which module comprises a rate controlling laminated wall surrounding a reservoir and has a portal for delivering drug from the system. The laminated wall comprises a semipermeable lamina in laminar arrangement with a microporous lamina to provide a wall that is permeable to an external fluid, impermeable to drug and maintains its integrity during the delivery of drug. The reservoir contains a drug, or a mixture of drug and solute which drug or solute is soluble in the fluid and exhibits an osmotic pressure gradient across the wall against the fluid. In operation, drug is released from the system by fluid being imbibed through the wall into the reservoir at a rate determined by the permeability of the wall and the osmotic pressure gradient across the wall thereby producing a solution of drug, or a solution of solute containing drug which solution is released through the portal at a controlled rate over a prolonged period of time.

Claims

1. An osmotic therapeutic system for the controlled dispensing of a beneficial drug formulation to a biological fluid environment of use comprising:

(a) a shaped laminated wall comprising;

a semipermeable lamina that is formed of a material permeable to the passage of an external fluid, substantially impermeable to the passage of drug, and essentially maintains its physical and chemical integrity in the biological environment of use, said semipermeable lamina in laminar arrangement with a lamina formed of a material that forms in the environment of use a microporous lamina having a plurality of micropores with paths through the lamina, said laminated wall surrounding and forming;

(b) a compartment containing a beneficial drug formulation;

(c) a passageway in the laminated wall communicating with the compartment and the exterior of the system for dispensing drug formulation from the system; and

,

(d) wherein in operation, when the system is in the environment of use, fluid from the environment is imbibed through the laminated wall into the compartment in a tendency towards osmotic equilibrium at a rate determined by the permeability of the laminated wall and the osmotic pressure gradient across the laminated wall, thereby forming a solution containing the drug formulation that is dispensed through the passageway at a controlled rate over a prolonged period of time.

2. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the drug is a member selected from the group of drugs that are soluble in the fluid and exhibit an osmotic pressure gradient across the laminated wall, and from the drugs that have limited solubility in the fiuid which drug is mixed with an osmotically effective solute that is soluble in the fluid and exhibits an osmotic pressure gradient across the laminated wall against the fluid.

3. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the semipermeable lamina additionally comprises a member selected from the group consisting of a stabilizing material that imparts integrity to the lamina, a flux regulator that aids in controlling the permeability of the lamina, a plasticizer that imparts flexibility to the lamina, a dispersant that aids in forming the lamina, and mixtures thereof.

4. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the material forming the semipermeable lamina is a member selected from the group consisting of cellulose acylates, cellulose diacylates, and cellulose triacylates.

5. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the system is sized, shaped and adapted for dispensing drug in the gastrointestinal tract.

6. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the system is sized, shaped and adapted for vaginal use.

7. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the system is sized, shaped and adapted to be placed in the anus.

8. The osmotic therapeutic system for dispensing a drug according to claim 1, wherein the lamina that forms the microporous lamina is thicker than the semipermeable lamina and which formed microporous lamina provides structural support for said semipermeable lamina.

9. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the microporous lamina is distant from the compartment and faces the biological environment and is formed in the biological environment, with the formed lamina having a plurality of micropores with paths through the lamina and permeable to the passage of fluid through said paths.

10. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the system is sized, shaped and adapted for oral administration and the drug is a member selected from the group consisting of locally and systemically acting drugs.

11. The osmotic therapeutic system for the controlled dispensing of a beneficial drug according to claim 1, wherein the semipermeable lamina contains a flux regulator selected from the group consisting of aliphatic diols, polyalkylene glycols, poly(α

,ω

)alkylenediols, esters of alkylene glycols and mixtures thereof.

12. The osmotic therapeutic system for the controlled dispensing of beneficial drug according to claim 1, wherein the semipermeable lamina also comprise a stabilizing material possessing different chemical and physical properties than the semipermeable lamina forming material, and which stabilizer material is a member selected from the group consisting of a cellulose ester and a cellulose ether.

13. The osmotic therapeutic system for the controlled dispensing of a beneficial drug according to claim 1, wherein the semipermeable lamina also comprises a cyclic or acyclic plasticizer selected from the group consisting of phthalates, phosphates, citrates, adipates, tartrates, sebacates, succinates, glycolates, glycerolates, benzoates, myristates, sulfonamides and halogenated phenyls.

14. The osmotic therapeutic system for dispensing drug according to claim 1, wherein the microporous lamina is formed in the biological environment by leaching from the lamina a a soluble component, which component is soluble in water and biological fluid, and the micropores thus formed by leaching the component have a radius of ##EQU22## wherein J is the volume flux per unit area, η

is the viscosity of the liquid, ε

is the porosity, Δ

P is the pressure difference across the lamina, Δ

x is the thickness of the lamina and τ

is the tortuosity.